{"title":"Intuitive Surgical vs Zimmer Biomet: Medical & surgical compared","url":"https://www.frontiertechintelligence.com/compare/intuitive-surgical-vs-zimmer-biomet","comparison":"Intuitive Surgical ranks 1 on the Robotics 100 with a score of 100; Zimmer Biomet ranks 60 with 81. Intuitive Surgical is ahead on deployment, production, commercials, progress, technology, positioning and leverage. Level on firepower. Intuitive Surgical is based in Sunnyvale, United States, Zimmer Biomet in Warsaw, United States. Intuitive Surgical: Established. Zimmer Biomet: Public. Intuitive Surgical is named in 12 signals and Zimmer Biomet in 11.","companies":[{"name":"Intuitive Surgical","url":"https://www.frontiertechintelligence.com/companies/intuitive-surgical","city":"Sunnyvale","country":"United States","stage":"Established","founded":null,"last_round":null,"positioning":"Intuitive Surgical is the US surgical-robotics leader with an installed base of 11,710 da Vinci and 1,096 Ion systems (468 placed in Q2-26 alone) and 14M cumulative procedures. Q2-26 revenue was $2.89B (+19%, 85% recurring) with procedures up 16%, a fast da Vinci 5 ramp (246 placed), and H1 free cash flow of $1.8B (+71%), with guidance raised. It is the top-scored company on the list.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":1,"score":100,"tier":"member","scores":{"gate_ne":["firepower"],"leverage":10,"position":10,"progress":10,"firepower":10,"commercial":10,"deployment":10,"production":10,"technology":10},"why":"Intuitive Surgical develops and sells da Vinci robotic surgical systems, including the da Vinci 5 platform cleared for cardiac procedures. Its core business is medical and surgical robotics.","segment":"Medical & surgical","layer":"Systems"},"signals_total":12,"facts_total":12},{"name":"Zimmer Biomet","url":"https://www.frontiertechintelligence.com/companies/zimmer-biomet","city":"Warsaw","country":"United States","stage":"Public","founded":null,"last_round":null,"positioning":"Zimmer Biomet is a US orthopedics company (NYSE:ZBH) whose ROSA robotic platform serves knee, hip, and shoulder procedures, now adding the Monogram semi-autonomous TKA system (FDA 510(k) in March 2025, an early-2027 launch) with a fully autonomous version in clinical study since July 2025. It completed the Monogram Technologies acquisition in October 2025. ROSA-specific revenue is not broken out of the group.","assessed_in":{"domain":"Robotics","list":"Robotics 100","rank":60,"score":81,"tier":"member","scores":{"gate_ne":["technology","firepower"],"leverage":6,"position":8,"progress":8,"firepower":10,"commercial":8,"deployment":8,"production":8,"technology":8},"why":"Zimmer Biomet develops and sells ROSA robotic surgical systems for orthopedic procedures, including robotic assistance and navigation for knee, hip, and brain surgery.","segment":"Medical & surgical","layer":"Systems"},"signals_total":11,"facts_total":4}],"note":"Assessment by Frontier Tech Intelligence; facts and signals carry their sources."}